Ozone Sauna — Limited and emerging: no trial has yet tested ozone sauna as a composite modality

The dominant safety risk of an ozone sauna is inhalation, not the heat. The US Environmental Protection Agency states that when inhaled, ozone can damage the lungs, and that relatively low amounts can cause chest pain, coughing, shortness of breath, and throat irritation, and can worsen existing respiratory conditions. EPA also reports that ozone concentrations produced by ozone generators can exceed health standards even when manufacturer instructions are followed. A session is therefore only as safe as the cabinet seal, the room ventilation, and the ozone destruct unit.

What an ozone sauna reliably delivers is a heat and sweat exposure, and that component has its own separate literature. A 2018 systematic review of regular dry sauna bathing in Evidence-Based Complementary and Alternative Medicine concluded that regular sauna bathing has potential health benefits across cardiovascular, rheumatological, and general wellbeing measures, while explicitly calling for higher-quality research on safety and optimal protocols. Framing an ozone sauna session as heat exposure with relaxation and comfort as the realistic outcome is defensible; attributing that experience to the ozone is not.

Ozone sauna is commonly marketed as a detox service. The underlying research is thinner than that framing implies. A 2012 systematic review of 24 studies found that arsenic, cadmium, lead, and mercury are measurable in sweat, and that in people with higher exposure or body burden sweat concentrations generally exceeded plasma or urine concentrations, with dermal excretion sometimes matching or exceeding daily urinary loss. The same authors noted wide variation in populations, collection methods, and concentrations, and concluded that appropriately sized trials are still needed to establish safe, effective therapeutic protocols. Detox should therefore be described as an open research question, not as a service outcome.

In an uncontrolled pilot study in women with endometriosis (n=8 for pain, n=10 for markers), sessions combining ozone sauna therapy and PEMF in a single device were followed by lower serum CRP and IL-1beta and reported pain improvement. With no control group and both modalities delivered together, the change cannot be attributed to PEMF.

Ozone sauna should not be described as a medical service or as an immune, antimicrobial, or disease-related intervention. US device labeling regulation (21 CFR 801.415) sets a maximum acceptable level of 0.05 part per million by volume of air for ozone in enclosed spaces occupied by people, and states that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. The same regulation notes that ozone concentrations high enough to act as a germicide are far greater than can be safely tolerated by people and animals, which removes the usual sanitizing rationale from consumer-facing copy.

There are no randomized controlled trials of ozone sauna itself. The clinical ozone literature studies other delivery routes, and it is methodologically fragile. A 2024 umbrella review in Frontiers in Physiology pooled eight systematic reviews covering 15 randomized trials and 3,685 patients with knee osteoarthritis, almost all using intra-articular injection. Three reviews reported statistically significant pain reduction versus placebo, ozone was not superior to comparators such as hyaluronic acid, functional improvement was inconsistent, and overall confidence in all eight included reviews was rated critically low on AMSTAR2. No included review covered transdermal or cabinet delivery, so none of it supports an ozone sauna benefit claim.